Señales en vivo de TCBP | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform...

Stats
Volumen de hoy	45 053.00
Volumen promedio	4.57M
Capitalización de mercado	4.66M
EPS	$0 ( 2022-12-12 )
Próxima fecha de ganancias	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.00900 (0.62%)

Insider Trading

Date	Person	Action	Amount	type
2022-11-30	Randall Diana Elizabeth	Buy	70 000	Series B Warrants
2022-11-30	Randall Mark Edward	Buy	70 000	Ordinary Shares [ADS]
2022-11-30	Randall Mark Edward	Buy	70 000	Series B Warrants
2022-11-30	Randall Kenneth Edward	Buy	70 000	Ordinary Shares [ADS]
2022-11-30	Randall Kenneth Edward	Buy	70 000	Series B Warrants

INSIDER POWER
100.00
Last 15 transactions
Buy: 790 803 \| Sell: 5 306 464

Volumen Correlación

Largo: 0.02 (neutral)

Corto: -0.47 (neutral)

Signal:(55.435) Neutral

TC Biopharm (Holdings) Correlación

10 Correlaciones Más Positivas
NEPT	0.903
VSTA	0.891
POWW	0.886
NOTV	0.886
TTCF	0.885
INVE	0.878
INFI	0.878
ACET	0.877
PLXP	0.876
VIH	0.875

10 Correlaciones Más Negativas
TUR	-0.895
IMMR	-0.894
MGI	-0.887
IBEX	-0.862
BILI	-0.854
ROST	-0.853
PBFS	-0.853
ACLX	-0.852
VLYPO	-0.85
OLK	-0.85

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

TC Biopharm (Holdings) Correlación - Moneda/Commodity

-0.41
( neutral )

-0.39
( neutral )

0.00
( neutral )

-0.36
( neutral )

0.34
( neutral )

TC Biopharm (Holdings) Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-24.38

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-24.38

FY	2022
Ingresos:	$3.84M
Beneficio Bruto:	$3.84M (100.00 %)
EPS:	$-2.02

FY	2021
Ingresos:	$1.98M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-24.19

Financial Reports:

No articles found.

TC Biopharm (Holdings)

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Actualizaciones en tiempo real para TC Biopharm (Holdings) [TCBP]

Upcoming Earnings Alert